Vernopharma SPRL
Vernopharma reported total assets of 568,206 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Vernopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets +190 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vernopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Vernopharma's financial analysis
- Solvency21.6%sector median: 49.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vernopharma
Vernopharma's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0441.952.982
- VAT number
- BE0441952982
- Peppol
- Registered · 0208:0441952982 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 17 Nov 1990
- Registered office
- 8531 Harelbeke
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of chemical products for industrial use (NACE 46851)
Vernopharma (SPRL) has been based in Harelbeke since 1990, active in: wholesale of chemical products for industrial use. For 2025, it reports a net loss of 6,342 € and equity of 122,490 €; its revenue is not published. Its solvency stands at 21.6%, below the median of its sector (49.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vernopharma
Companies in the same business, of comparable size and area, outside its group.
- Melon-Wislez Wholesale of pharmaceutical and medical goods Waimes · balance sheet 901,346 €
- Apotheek van Damme Retail sale of pharmaceutical products Bruges · balance sheet €1.61m
- Pharmacie Concorde de Namur Retail sale of pharmaceutical products Sambreville · balance sheet 657,808 €
- Diepenbeek Markt Farma Retail sale of pharmaceutical products Diepenbeek · balance sheet 505,908 €
- Doceo Wholesale of chemical products Villers-le-Bouillet · balance sheet 908,040 €
- Copharem Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.24m
- Pharmahealth Retail sale of pharmaceutical products Zottegem · balance sheet 607,296 €
- DUO-Pharma Retail sale of pharmaceutical products Orp-Jauche · balance sheet 479,265 €
Frequently asked questions about Vernopharma
What is the revenue of Vernopharma?
Vernopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vernopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0441952982 for Vernopharma, if the company is VAT-registered. Its company number (CBE) is 0441.952.982.
Where is the registered office of Vernopharma?
According to the CBE register, the registered office of Vernopharma is in 8531 Harelbeke.
What is the equity of Vernopharma?
At the close of the 2025 financial year, the equity of Vernopharma amounts to 122,490 €, a solvency of 21.6% of total assets.
Who manages Vernopharma?
The register lists 2 active mandates at Vernopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vernopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →